Among the six core GS&MetabolismRDEGs, LYVE1, AHR and TREM1 are emerging regulators of glymphatic function and metabolic homeostasis, offering a new perspective on AD inflammatory pathology. Here, LYVE1 is linked to Alzheimer disease.